Focused Monitoring After Heart Failure Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Focused Monitoring After Heart Failure Trials

Published:2024-05 Issue:5 Volume:99 Page:702-704
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Le Jemtel Thierry H.,Samson Rohan^ORCID

Publisher

Elsevier BV

Reference9 articles.

1. DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med,2019

2. EMPEROR-Reduced Trial Investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure;Packer;N Engl J Med,2020

3. LIFE Investigators. Effect of treatment with sacubitril/valsartan in patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial;Mann;JAMA Cardiol,2022

4. LIFE Investigators. Tolerability of sacubitril/valsartan in patients with advanced heart failure: analysis of the LIFE trial run-in;Vader;JACC Heart Fail,2022

5. Long-term survival in severe heart failure in patients treated with enalapril: ten year follow-up of CONSENSUS I;Swedberg;Eur Heart J,1999

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3